Taiwan Advance Bio-Pharmaceutical Inc. (4186.TWO)
TWD 13.5
(-0.74%)
TWD 13.5
(-0.74%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -10.68 Million TWD | -436.97% |
| 2022 | 3.17 Million TWD | 102.67% |
| 2021 | -118.52 Million TWD | -37.2% |
| 2020 | -86.39 Million TWD | 50.54% |
| 2019 | -174.66 Million TWD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | -2.2 Million TWD | -117.09% |
| 2024 Q2 | -2.2 Million TWD | 0.0% |
| 2023 FY | -10.68 Million TWD | -436.97% |
| 2023 Q4 | 12.9 Million TWD | 0.0% |
| 2023 Q3 | 12.9 Million TWD | 170.73% |
| 2023 Q1 | -18.25 Million TWD | -681.58% |
| 2023 Q2 | -18.25 Million TWD | 0.0% |
| 2022 Q4 | -2.33 Million TWD | 0.0% |
| 2022 FY | 3.17 Million TWD | 102.67% |
| 2022 Q3 | -2.33 Million TWD | 0.0% |
| 2021 FY | -118.52 Million TWD | -37.2% |
| 2020 FY | -86.39 Million TWD | 50.54% |
| 2019 FY | -174.66 Million TWD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| SYN-TECH Chem. & Pharm. Co., Ltd. | 251.01 Million TWD | 104.256% |
| Level Biotechnology Inc. | 62.9 Million TWD | 116.981% |
| Sagittarius Life Science Corp | -55.03 Million TWD | 80.592% |
| NeoCore Technology Co., Ltd. | -64.64 Million TWD | 83.476% |
| TaiMed Biologics Inc. | -194.81 Million TWD | 94.517% |
| GlycoNex Incorporation | -178.36 Million TWD | 94.011% |
| VBI | -6.6 Million TWD | -61.824% |
| GeneReach Biotechnology Corp. | -166.27 Million TWD | 93.576% |
| Visgeneer Inc. | -19.58 Million TWD | 45.469% |
| Mycenax Biotech Inc. | -682.84 Million TWD | 98.436% |
| Sunmax Biotechnology Co., Ltd. | 625.7 Million TWD | 101.707% |
| G&E Herbal Biotechnology Co., Ltd. | 72.4 Million TWD | 114.754% |
| Medigen Vaccine Biologics Corporation | -1.15 Billion TWD | 99.079% |
| TaiwanJ Pharmaceuticals Co., Ltd. | -6.04 Million TWD | -76.65% |
| Enimmune corporation | -223.74 Million TWD | 95.226% |
| TaiRx, Inc. | -212.29 Million TWD | 94.968% |
| CHO Pharma, Inc. | -306.08 Million TWD | 96.51% |
| EirGenix Inc. | -915.2 Million TWD | 98.833% |
| BioLASCO Taiwan Co., Ltd. | 49.74 Million TWD | 121.474% |
| Sunny Pharmtech Inc. | -63.32 Million TWD | 83.13% |
| Lin BioScience, Inc. | -687.19 Million TWD | 98.446% |
| BioGend Therapeutics Co., Ltd. | -156.32 Million TWD | 93.167% |
| Feng Chi Biotech Corp. | 22.79 Million TWD | 146.867% |
| Bio Preventive Medicine Corp. | -73.28 Million TWD | 85.424% |
| Lukas Biomedical Inc. | -47.35 Million TWD | 77.442% |
| RBC Bioscience Corporation | 6.43 Million TWD | 266.128% |
| BiOptic Inc. | 37.74 Million TWD | 128.299% |
| BRIM Biotechnology, Inc. | -688.02 Million TWD | 98.447% |
| Shine-On BioMedical Co.,Ltd. | -37.16 Million TWD | 71.258% |
| Great Novel Therapeutics Biotech & Medicals | -61.54 Million TWD | 82.642% |
| Syngen Biotech Co.,Ltd. | 274.82 Million TWD | 103.887% |
| Anti-Microbial Savior BioteQ Co., Ltd | -51.78 Million TWD | 79.371% |
| SynCore Biotechnology Co.,Ltd | -38.17 Million TWD | 72.016% |
| Genomics BioSci & Tech. Co.,Ltd. | -168.06 Million TWD | 93.644% |
| Neith Corporation | -40.03 Million TWD | 73.317% |
| Advagene Biopharma Co., Ltd. | -92.11 Million TWD | 88.403% |
| NaviFUS Corp. | -65.72 Million TWD | 83.748% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | -88.08 Million TWD | 87.874% |
| Sinew Pharma Inc. | -170.92 Million TWD | 93.75% |
| Andros Pharmaceuticals Co.,Ltd | -68.15 Million TWD | 84.328% |
| Greenyn Biotechnology Co., Ltd | 130.66 Million TWD | 108.175% |
| Lumosa Therapeutics Co., Ltd. | -238.04 Million TWD | 95.513% |
| AP Biosciences Inc | -339.29 Million TWD | 96.852% |
| Medigen Biotechnology Corp. | -561.29 Million TWD | 98.097% |
| 3D Global Biotech Inc. | -57.95 Million TWD | 81.567% |
| Pharmosa Biopharm Inc. | 8.45 Million TWD | 226.325% |
| Intech Biopharm Corporation | -337.98 Million TWD | 96.84% |
| Oneness Biotech Co., Ltd. | -1.31 Billion TWD | 99.186% |
| Eusol Biotech Co.,Ltd. | -51.61 Million TWD | 79.304% |
| TWi Biotechnology, Inc. | -170.68 Million TWD | 93.742% |
| Ever Supreme Bio Technology Co., Ltd | 539.39 Million TWD | 101.98% |
| TCI GENE Inc. | 11.67 Million TWD | 191.51% |
| MegaPro Biomedical Co., Ltd | -127.54 Million TWD | 91.625% |
| Senhwa Biosciences, Inc. | -296.3 Million TWD | 96.395% |
| Taiwan Bio Therapeutics Co., Ltd | -217.51 Million TWD | 95.089% |
| NatureWise Biotech & Medicals Corporation | 10.12 Million TWD | 205.553% |
| PharmaEngine, Inc. | 274.65 Million TWD | 103.889% |
| Savior Lifetec Corporation | 30.03 Million TWD | 135.571% |
| TaiGen Biopharmaceuticals Holdings Limited | 136.73 Million TWD | 107.812% |
| OBI Pharma, Inc. | -1.04 Billion TWD | 98.979% |
| Meribank Biotech Co., Ltd | -125.34 Million TWD | 91.478% |
| Acepodia, Inc. | -817.31 Million TWD | 98.693% |
| Caliway Biopharmaceuticals Co., Ltd. | -488.45 Million TWD | 97.813% |